MRVI:NASDAQMaravai LifeSciences Holdings, Inc. analysis
Data as of Sep 27, 2026 - not real-time
- Latest price
- $7.60
- Risk: high
- 9/10High risk
Summary
Maravai LifeSciences Holdings, Inc. is priced at $7.60 and its moving averages line up in bullish order, the shorter sitting above the longer. Across the trailing 30 sessions it gained 31.5%. With RSI at 57.3 the momentum picture is neutral, alongside a bullish MACD signal. Price has been bracketed by support at $6.49 and resistance at $8.18.
The company is not currently profitable on a trailing basis, so earnings multiples offer no valuation support. Revenue is growing at 8.5% on a -37.1% profit margin.
On a 1-10 scale the risk profile lands at 9 — high. With 30-day volatility of 95.1%, a beta of 1.28 and a maximum drawdown of 29.6%, position sizing matters more than entry timing here. The wider market backdrop reads extreme greed at 95 on the fear-greed composite.
All three time horizons resolve to hold, carrying 3/10 conviction.
The company is not currently profitable on a trailing basis, so earnings multiples offer no valuation support. Revenue is growing at 8.5% on a -37.1% profit margin.
On a 1-10 scale the risk profile lands at 9 — high. With 30-day volatility of 95.1%, a beta of 1.28 and a maximum drawdown of 29.6%, position sizing matters more than entry timing here. The wider market backdrop reads extreme greed at 95 on the fear-greed composite.
All three time horizons resolve to hold, carrying 3/10 conviction.
Top market events
- Maravai LifeSciences Holdings, Inc. MRVI came out with a quarterly loss of $0.02 per share versus the Zacks Consensus...
- Maravai LifeSciences Holdings, Inc. MRVI might move higher on growing optimism about its earnings prospects, which is...
- Maravai LifeSciences MRVI delivered earnings and revenue surprises of +60.
Market outlook
Short term
< 1 yearNeutral
Model confidence1/101 out of 10
Key factors
- Short-term moving averages stacked above long-term ones
- Trading above the 200-day average of 4.75
- MACD momentum is positive
Medium term
1–3 yearsNeutral
Model confidence1/101 out of 10
Key factors
- Short-term moving averages stacked above long-term ones
- Trading above the 200-day average of 4.75
- 30-day volatility of 95.1%
Long term
> 3 yearsNeutral
Model confidence3/103 out of 10
Key factors
- Negative profit margin of -37.1%
- Negative return on equity of -33.0%
- Negative free cash flow
Key metrics
Financial health
Revenue Growth8.50%
Profit Margin-37.07%
P/E Ratio-72.3
ROE-33.05%
ROA-5.71%
Debt/Equity61.34
P/B Ratio5.5
Op. Cash Flow$-25261000
Free Cash Flow$-3623125
Industry P/E30.5
Technical analysis
TrendBullish
RSI57.3
Support$6.49
Resistance$8.18
MA 20$7.20
MA 50$7.02
MA 200$4.75
MACDBullish
VolumeDecreasing
Fear & Greed Index94.88
Valuation
Target Price$7.42
Upside/Downside-2.41%
GradeOvervalued
TypeGrowth
Risk assessment
Beta1.28
Volatility95.05%
Sector RiskMedium
Reg. RiskHigh
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium
Similar tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.